It’s been a strong year for biotech IPOs and Wednesday shaped up to be a particularly busy day as four life science firms debuted on the public markets.
So far this year, 72 companies have gone public, according to IPO research firm Renaissance Capital. That total is down 20 percent compared to the same period a year ago. But healthcare IPOs continue to lead the pack, with 33 companies going public—the most of any sector. Here’s a recap of Wednesday evening’s life science IPO activity.